Loss of function of KDM6A causes squamous-like metastatic pancreatic cancer through aberrant activation of super-enhancers at the loci of MYC and RUNX3 oncogenes and consequent MYC and RUNX3 over-expression [18]. This evidence concerns the gene KDM6A and familial pancreatic carcinoma.